Naturally Splendid Enterprises Ltd. NSPDF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

21/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Naturally Splendid Enterprises Ltd. (NSPDF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 19/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

17/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

7/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — NSPDF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$-1.67	$132.58K	$-2.75M	-2070.5%
2014	$-0.89	$234.76K	$-1.8M	-764.9%
2015	$-2.00	$301.71K	$-6.87M	-2277.8%
2016	$-0.65	$7.35M	$-2.62M	-35.7%
2017	$-0.89	$1.77M	$-4.58M	-258.1%
2018	$-0.24	$2.07M	$-1.6M	-77%
2019	$-0.88	$3.04M	$-7.03M	-231.4%
2020	$-0.41	$1.58M	$-4.66M	-295.6%
2021	$-0.22	$763.8K	$-3.14M	-411.4%
2022	$0.00	$0.00	$0.00	-